Financials Green Thumb Industries Inc.

Equities

GTII

CA39342L1085

Drug Retailers

Market Closed - Canadian Securities Exchange 03:59:59 2024-05-23 pm EDT 5-day change 1st Jan Change
15.59 CAD 0.00% Intraday chart for Green Thumb Industries Inc. -13.10% +4.84%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,029 5,290 5,144 2,090 2,658 2,698 - -
Enterprise Value (EV) 1 2,135 5,305 5,154 2,448 3,067 3,011 2,862 2,652
P/E ratio -30.7 x 350 x 67.6 x 177 x 74.8 x 36.7 x 34.3 x 19.2 x
Yield - - - - - - - -
Capitalization / Revenue 9.38 x 9.5 x 5.76 x 2.05 x 2.52 x 2.4 x 2.23 x 2.03 x
EV / Revenue 9.86 x 9.53 x 5.77 x 2.41 x 2.91 x 2.68 x 2.36 x 2 x
EV / EBITDA 64.5 x 29.5 x 16.7 x 7.86 x 9.41 x 8.59 x 7.73 x 6.71 x
EV / FCF -20 x 147 x -92.4 x -117 x 622 x 27.5 x 20.2 x 16.2 x
FCF Yield -4.99% 0.68% -1.08% -0.86% 0.16% 3.64% 4.95% 6.17%
Price to Book 2.23 x 5.67 x 2.78 x 1.26 x 1.38 x 1.51 x - -
Nbr of stocks (in thousands) 206,226 216,096 230,651 236,555 237,011 237,094 - -
Reference price 2 9.839 24.48 22.30 8.835 11.22 11.38 11.38 11.38
Announcement Date 3/26/20 3/17/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 216.4 556.6 893.6 1,017 1,055 1,125 1,212 1,328
EBITDA 1 33.1 179.6 307.8 311.5 325.8 350.6 370.3 395.2
EBIT 1 -28.71 106.1 214.8 209.6 184.6 220.9 226.2 240.1
Operating Margin -13.27% 19.06% 24.04% 20.6% 17.51% 19.63% 18.66% 18.09%
Earnings before Tax (EBT) 1 -53.39 102.9 205 108.4 156 200.1 208.6 223.1
Net income 1 -62.03 14.99 75.44 11.98 36.27 71.03 79.77 160.9
Net margin -28.67% 2.69% 8.44% 1.18% 3.44% 6.31% 6.58% 12.12%
EPS 2 -0.3200 0.0700 0.3300 0.0500 0.1500 0.3102 0.3320 0.5933
Free Cash Flow 1 -106.6 36.12 -55.8 -20.94 4.933 109.5 141.6 163.6
FCF margin -49.25% 6.49% -6.24% -2.06% 0.47% 9.73% 11.68% 12.32%
FCF Conversion (EBITDA) - 20.11% - - 1.51% 31.23% 38.23% 41.39%
FCF Conversion (Net income) - 240.91% - - 13.6% 154.18% 177.44% 101.64%
Dividend per Share - - - - - - - -
Announcement Date 3/26/20 3/17/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 243.6 242.6 254.3 261.2 259.3 248.5 252.4 275.4 278.2 275.8 277.6 283.8 289.7 292.9 301.4
EBITDA 1 76.01 67.04 78.74 84.46 81.24 76.23 75.82 82.99 90.8 90.55 85.17 87.08 88.63 88.89 92.08
EBIT 1 54.38 54.55 62.26 48.76 43.99 44.2 41.06 49.03 50.34 70.67 51.42 52.2 52.64 60 61.39
Operating Margin 22.33% 22.49% 24.48% 18.67% 16.97% 17.78% 16.27% 17.8% 18.09% 25.62% 18.52% 18.39% 18.17% 20.48% 20.36%
Earnings before Tax (EBT) 1 50.46 60.82 63.07 43.12 -58.57 43.04 39.46 45.33 28.22 63.5 46.44 46.94 48.02 55.13 56.54
Net income 1 22.81 28.94 24.44 9.829 -51.23 9.139 13.4 10.51 3.216 31.08 12.49 14.1 15.27 16.17 16.65
Net margin 9.36% 11.93% 9.61% 3.76% -19.76% 3.68% 5.31% 3.82% 1.16% 11.27% 4.5% 4.97% 5.27% 5.52% 5.52%
EPS 2 0.1000 0.1200 0.1000 0.0400 -0.2200 0.0400 0.0500 0.0500 0.0100 0.1300 0.0518 0.0642 0.0673 0.0650 0.0700
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/1/22 5/4/22 8/3/22 11/2/22 2/28/23 5/3/23 8/8/23 11/9/23 2/28/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 106 15.3 9.51 358 409 313 164 -
Net Cash position 1 - - - - - - - 46
Leverage (Debt/EBITDA) 3.19 x 0.0852 x 0.0309 x 1.15 x 1.254 x 0.8932 x 0.443 x -
Free Cash Flow 1 -107 36.1 -55.8 -20.9 4.93 110 142 164
ROE (net income / shareholders' equity) -10.4% 1.75% 5.96% 4.55% 2.15% 3.15% 1.9% 7%
ROA (Net income/ Total Assets) -7.87% 1.21% 4.03% 3.1% 1.47% 10% 5.65% 5.1%
Assets 1 788.4 1,238 1,872 385.8 2,462 710.3 1,412 3,156
Book Value Per Share 2 4.410 4.320 8.030 6.990 8.100 7.520 - -
Cash Flow per Share 2 -0.0900 0.4500 0.5800 0.6700 0.9400 1.080 1.060 1.360
Capex 1 88.6 59.8 188 180 220 110 79.6 117
Capex / Sales 40.92% 10.74% 21.02% 17.64% 20.87% 9.76% 6.56% 8.8%
Announcement Date 3/26/20 3/17/21 3/1/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
11.38 USD
Average target price
18.65 USD
Spread / Average Target
+63.88%
Consensus
  1. Stock Market
  2. Equities
  3. GTII Stock
  4. Financials Green Thumb Industries Inc.